INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG

NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation ("Neogen" or the "Company") (NASDAQ: NEOG).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

PRNewsWire • 11 hours ago

NEOG vs. WFCF: Which Food Safety Stock Has Better Prospects?

Neogen beats Where Food Comes From in revenue growth and recovery potential, but higher debt and integration risks complicate the food safety stock showdown.

Zacks Investment Research • Oct 20, 2026

Neogen Corporation (NEOG) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa. , Oct. 15, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G.

GlobeNewsWire • Oct 15, 2026

Securities Fraud Investigation Into Neogen Corporation (NEOG) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

LOS ANGELES, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) investors concerning the Company's possible violations of the federal securities laws.

GlobeNewsWire • Oct 15, 2026

Securities Fraud Investigation Into Neogen Corporation (NEOG) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES, Oct. 14, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) on behalf of investors concerning the Company's possible violations of federal securities laws.

GlobeNewsWire • Oct 14, 2026

3 Medical Product Stocks Positioned to Ride on the Industry Tailwinds

Here, we highlight three medical product stocks, ICUI, NEOG and TRLV, which are well positioned to benefit from industry tailwinds and could be worth adding to investors' portfolios.

Zacks Investment Research • Oct 9, 2026

Neogen Corporation: Promising Recurring Demand With Food Safety

I believe Neogen's recurring food safety products provide a foundation for its operating recovery. However, management has to execute carefully and proceed with the Petrifilm transition, which, if successful, should improve its cash flows long-term. Also, NEOG's recent genomics sale should give it extra flexibility, but we have to wait and see until we know how much its earnings may decrease as a result.

Seeking Alpha • Oct 8, 2026

Neogen Investor Day Sets Path for Growth, 30% EBITDA Margin by 2031

Neogen NASDAQ: NEOG outlined a multi-year strategy at its first Investor Day, emphasizing a shift from business stabilization toward accelerated growth, higher margins and stronger cash generation. Management said the company has delivered positive core growth for four consecutive quarters and is targeting high-single-digit to low-double-digit long-term revenue growth, adjusted gross margins in the high-50% range, adjusted EBITDA margins of approximately 30% and free-cash-flow conversion of about 80% by fiscal 2031.

MarketBeat • Oct 8, 2026

Neogen Shifts Focus to Scale Profitable Growth

Neogen Corp. (NASDAQ:NEOG) stock fell on Wednesday even after the company reported better-than-expected first-quarter financial results.

Benzinga • Oct 7, 2026

Neogen (NEOG) Securities Investigation Notice - Levi & Korsinsky

Neogen shares fell 7.22% after an FDA warning concerning the recalled Neogen Vet product HYCOAT, which reporting tied to fungal contamination and at least 20 horse deaths. NEW YORK, Oct. 7, 2026 /PRNewswire/ -- Neogen (NASDAQ: NEOG) shares fell over 7% after an FDA warning concerning HYCOAT, a recalled Neogen Vet product that reporting linked to fungal contamination and at least 20 horse deaths.

PRNewsWire • Oct 7, 2026